Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf344 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Brian Swinnen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Myocardial Infarction, Postoperative Complications. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation's Dekker program, Dutch Heart Foundation’s Dekker program.
Abstract (Originalsprache)
Objectives
The definitions of periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG) are heavily debated. A European Association for Cardiothoracic Surgery (EACTS)-endorsed international survey was conducted to evaluate current clinical practices and to reach a consensus-based agreement on the diagnostic characteristics required for a potential future PMI definition.
Methods
The questionnaire complied with the CHERRIES guideline. A pilot version underwent iterative testing. The final version was distributed to all members of EACTS and allied specialties. The questionnaire evaluated definitions, biomarkers, and required diagnostic accuracy and was distributed between August-November 2024.
Results
The questionnaire was completed by 175 respondents (surgeons: 71.4%, cardiologists: 20.6%, intensivists: 5.1%, other: 2.9%) from 29 countries. A specific definition of PMI was used by 46.4% of respondents (Universal Definition of Myocardial Infarction [UDMI]-4: 67.4%, Society of Cardiovascular Angiography and Interventions [SCAI]: 16.3%, second Academic Research Consortium [ARC-2]: 6.1%, other: 10.2%). Respondents identified biomarker concentrations defining PMI with supporting (imaging) evidence (high-sensitivity cardiac troponin T [hs-cTnT]: 489 ng/L, high-sensitivity cardiac troponin I [hs-cTnI]: 425 ng/L, CKMB-mass: 90ug/L, CKMB-activity: 100 U/L) and without (hs-cTnT: 931 ng/L, hs-cTnI: 1458 ng/L, CKMB-mass: 100ug/L, CKMB-activity: 300UL). The lowest acceptable sensitivity and specificity thresholds for a future definition were 95% [90%-95%] and 90% [80%-95%], respectively, while sensitivity was deemed more important than specificity (79.8% vs 20.2%, P < .001).
Conclusions
The use of PMI definitions varies widely, though UDMI-4 is most frequently employed. Our findings highlight the need for a standardized, CABG-specific PMI definition with robust diagnostic accuracy to enable consistent diagnoses and a common clinical language.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
- Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
- Department of Cardiothoracic Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
- Department of Cardiothoracic Surgery, Isala Heart Centre, Zwolle, The Netherlands.
- Department of Cardiology, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
ORCID-Profile: Casper Mihl, Alma M A Mingels, Patrick O Myers, Raffaele De Caterina, Steven Jacobs, Roberto Lorusso, Elham Bidar, Jos G Maessen, Can Gollmann-Tepeköylü, Samuel Heuts
Förderung
- Dutch Heart Foundation's Dekker program
- Dutch Heart Foundation’s Dekker program
Zitieren
APA
Swinnen, B., Olsthoorn, J. R., Mihl, C., Smulders, M. W., Singh, S. K., van Brakel, T., van der Horst, I. C. C., Mingels, A. M. A., Myers, P. O., van 'tHof, A. W. J., Gorgels, A. P. M., Thielmann, M., De Caterina, R., Cerqueira, R. J., Bonaros, N., Oosterlinck, W., Jacobs, S., Lorusso, R., Bidar, E., …, & Heuts, S. (2025). Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf344
Vancouver
Swinnen B, Olsthoorn JR, Mihl C, Smulders MW, Singh SK, van Brakel T, et al. Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf344
BibTeX
@article{Swinnen2025,
author = {Swinnen, Brian and Olsthoorn, Jules R and Mihl, Casper and Smulders, Martijn W and Singh, Sandeep K and van Brakel, Thomas and van der Horst, Iwan C C and Mingels, Alma M A and Myers, Patrick O and van 'tHof, Arnoud W J and Gorgels, Anton P M and Thielmann, Matthias and De Caterina, Raffaele and Cerqueira, Rui J and Bonaros, Nikolaos and Oosterlinck, Wouter and Jacobs, Steven and Lorusso, Roberto and Bidar, Elham and Wildberger, Joachim E and Maessen, Jos G and Gaudino, Mario and Gollmann-Tepeköylü, Can and Heuts, Samuel},
title = {Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf344}
}
EUVIMED